Abstract
SELECTIVE serotonin reuptake inhibitors block the uptake of serotonin into thrombocytes. One of the functions of serotonin in thrombocytes is to promote platelet aggregation. When serotonin levels are depleted after several weeks of treatment, the altered platelet function leads to prolonged bleeding time, thereby increasing the risk of abnormal bleeding. Selective serotonin reuptake inhibitors may contribute substantially to the burden of abnormal bleeding after surgical procedures in the general population, due to the large number of users of selective serotonin reuptake inhibitors. In patients taking the combination of selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs, the risk of abnormal bleeding is thought to be even higher. We report a case of abnormal bleeding after an oral surgical procedure leading to airway compromise in a patient taking a selective serotonin reuptake inhibitor and a nonsteroidal antiinflammatory drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.